{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:22Z","timestamp":1707525142086},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,12]]},"DOI":"10.7759\/cureus.41766","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:29:16Z","timestamp":1689164956000},"source":"Crossref","is-referenced-by-count":0,"title":["High-Dose Oral Amiodarone for Cardioversion of Atrial Fibrillation: A Case Report"],"prefix":"10.7759","author":[{"given":"Giovanni","family":"Reynaldo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachmat","family":"Hamonangan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingkan","family":"Naomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas Daniel","family":"Widjanarko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej J","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020, 127:4-20. 10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe BP","year":"2013","unstructured":"Krijthe BP, Kunst A, Benjamin EJ, et al.. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013, 34:2746-51. 10.1093\/eurheartj\/eht280","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"Chao TF","year":"2018","unstructured":"Chao TF, Liu CJ, Tuan TC, Chen TJ, Hsieh MH, Lip GY, Chen SA. Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study. Chest. 2018, 153:453-66. 10.1016\/j.chest.2017.10.001","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314267","article-title":"Mechanisms of atrial fibrillation","volume":"105","author":"Wijesurendra RS","year":"2019","unstructured":"Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019, 105:1860-7. 10.1136\/heartjnl-2018-314267","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01458","article-title":"Atrial fibrillation mechanisms and implications for catheter ablation","volume":"9","author":"Cheniti G","year":"2018","unstructured":"Cheniti G, Vlachos K, Pambrun T, et al.. Atrial fibrillation mechanisms and implications for catheter ablation. Front Physiol. 2018, 9:1458. 10.3389\/fphys.2018.01458","journal-title":"Front Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1705153","article-title":"Etiology, pathology, and classification of atrial fibrillation","volume":"29","author":"Nayak S","year":"2020","unstructured":"Nayak S, Natarajan B, Pai RG. Etiology, pathology, and classification of atrial fibrillation. Int J Angiol. 2020, 29:65-71. 10.1055\/s-0040-1705153","journal-title":"Int J Angiol"},{"key":"ref7","article-title":"miR-155 expression utilization as a potential diagnostic biomarker of heart failure: a systematic review","volume":"26","author":"Tandarto K","year":"2023","unstructured":"Tandarto K, Tjendrawinata I, Sukmadi N, Laksono S. miR-155 expression utilization as a potential diagnostic biomarker of heart failure: a systematic review. J Health Transl Med. 2023, 26:105-14.","journal-title":"J Health Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da D","year":"2020","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, et al.. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2020, 8:222-37. 10.1002\/ehf2.13144","journal-title":"ESC Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris PE","year":"2017","unstructured":"Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017, 40:413-8. 10.1002\/clc.22667","journal-title":"Clin Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.016926","article-title":"CHA(2)DS(2)-VASc score (congestive heart failure, hypertension, age \u226575 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65-74, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study","volume":"48","author":"Kim TH","year":"2017","unstructured":"Kim TH, Yang PS, Uhm JS, et al.. CHA(2)DS(2)-VASc score (congestive heart failure, hypertension, age \u226575 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65-74, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study. Stroke. 2017, 48:1524-30. 10.1161\/STROKEAHA.117.016926","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa426","article-title":"Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future","volume":"23","author":"Heijman J","year":"2021","unstructured":"Heijman J, Hohnloser SH, Camm AJ. Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future. Europace. 2021, 23:ii14-22. 10.1093\/europace\/euaa426","journal-title":"Europace"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/psb.1828","article-title":"Classification and choice of antiarrhythmic therapies","volume":"31","author":"Barton AK","year":"2020","unstructured":"Barton AK, McGowan M, Smyth A, Wright GA, Gardner RS. Classification and choice of antiarrhythmic therapies. Prescriber. 2020, 31:11-7. 10.1002\/psb.1828","journal-title":"Prescriber"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner R","year":"2009","unstructured":"Dankner R, Shahar A, Novikov I, Agmon U, Ziv A, Hod H. Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management. Cardiology. 2009, 112:270-8. 10.1159\/000151703","journal-title":"Cardiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318214876d","article-title":"2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"123","author":"Fuster V","year":"2011","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, et al.. 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2011, 123:e269-367. 10.1161\/CIR.0b013e318214876d","journal-title":"Circulation"},{"key":"ref15","article-title":"Amiodarone: guidelines for use and monitoring","volume":"68","author":"Siddoway LA","year":"2003","unstructured":"Siddoway LA. Amiodarone: guidelines for use and monitoring. Am Fam Physician. 2003, 68:2189-96.","journal-title":"Am Fam Physician"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002903.pub2","article-title":"Withdrawn: electrical cardioversion for atrial fibrillation and flutter","volume":"11","author":"Mead GE","year":"2017","unstructured":"Mead GE, Elder A, Flapan AD, Cordina J. Withdrawn: electrical cardioversion for atrial fibrillation and flutter. Cochrane Database Syst Rev. 2017, 11:CD002903. 10.1002\/14651858.CD002903.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12841","article-title":"Clinical effects of intravenous to oral amiodarone transition strategies in critically ill adult patients","volume":"44","author":"Arnouk S","year":"2019","unstructured":"Arnouk S, Aberle C, Altshuler D, Merchan C, Piper GL, Papadopoulos J. Clinical effects of intravenous to oral amiodarone transition strategies in critically ill adult patients. J Clin Pharm Ther. 2019, 44:693-700. 10.1111\/jcpt.12841","journal-title":"J Clin Pharm Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.06.011","article-title":"Management of atrial fibrillation in 2021: an updated comparison of the current CCS\/CHRS, ESC, and AHA\/ACC\/HRS guidelines","volume":"37","author":"Cheung CC","year":"2021","unstructured":"Cheung CC, Nattel S, Macle L, Andrade JG. Management of atrial fibrillation in 2021: an updated comparison of the current CCS\/CHRS, ESC, and AHA\/ACC\/HRS guidelines. Can J Cardiol. 2021, 37:1607-18. 10.1016\/j.cjca.2021.06.011","journal-title":"Can J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2012.03.015","article-title":"Single high oral dose amiodarone for cardioversion of recent onset atrial fibrillation","volume":"21","author":"Nadarasa K","year":"2012","unstructured":"Nadarasa K, Williams MJ. Single high oral dose amiodarone for cardioversion of recent onset atrial fibrillation. Heart Lung Circ. 2012, 21:444-8. 10.1016\/j.hlc.2012.03.015","journal-title":"Heart Lung Circ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2019.07.004","article-title":"Adverse reactions of amiodarone","volume":"16","author":"Colunga Biancatelli RM","year":"2019","unstructured":"Colunga Biancatelli RM, Congedo V, Calvosa L, Ciacciarelli M, Polidoro A, Iuliano L. Adverse reactions of amiodarone. J Geriatr Cardiol. 2019, 16:552-66. 10.11909\/j.issn.1671-5411.2019.07.004","journal-title":"J Geriatr Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1734","article-title":"Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation","volume":"21","author":"Capucci A","year":"2000","unstructured":"Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J. 2000, 21:66-73. 10.1053\/euhj.1999.1734","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159584-high-dose-oral-amiodarone-for-cardioversion-of-atrial-fibrillation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:22Z","timestamp":1707509002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159584-high-dose-oral-amiodarone-for-cardioversion-of-atrial-fibrillation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.41766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,12]]}}}